Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.
Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.
bio-rad實驗室股票上漲，花旗集團維持對該股票的買入評級，並將目標股價從400美元上調至450美元。
Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.
bio-rad實驗室股價上漲，因花旗集團維持買入評級，並將股票目標價從400美元上調至450美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間